🇺🇸 FDA
Patent

US 11559574

Whole-cell cancer vaccines and methods for selection thereof

granted A61KA61K2039/5152A61K2039/5156

Quick answer

US patent 11559574 (Whole-cell cancer vaccines and methods for selection thereof) held by BriaCell Therapeutics Corp. expires Mon Jan 19 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
BriaCell Therapeutics Corp.
Grant date
Tue Jan 24 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 19 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
81
CPC classes
A61K, A61K2039/5152, A61K2039/5156, A61K2039/55522, A61K39/0011